Skylark Holdings3197.T
Diluted EPS at ¥73.6 in FY December 2025 sits 21% below the ¥92.8 print of FY December 2016. Eleven years of cumulated free cash flow of approximately ¥372bn produced zero treasury-stock balance. The forward P/E at 32.6x prices a compounder ; the mid-cycle reconstruction prices a mature cash-flow generator at 15–18x. Spot is ¥2,830 ; reconstructed fair value lands at ¥1,000–1,350. The diagnostic is the EBIT margin trajectory across the four prints between February 2027 and August 2027.
Mid-cycle EBIT at 5.7–6.2% margin on ¥460–470bn revenue produces ¥27–29bn of operating profit.
After 36% effective tax and ¥3.5bn net interest, mid-cycle net income lands at ¥15–17bn ; diluted EPS at ¥65–75 on 227.5m shares.
At 15–18x P/E forward justified by archetype-B mid-tier comparables (Darden 17–19x, Cracker Barrel 12–14x), reconstructed fair value sits at ¥975–1,350 per share.
Spot is ¥2,830 at 19 May 2026, ¥643.9bn market cap, 32.6x forward P/E.
The dossier rests on one question. Is the 6.5% EBIT margin at FY December 2025 the visible expression of a 6.0–6.5% structural mid-cycle floor approaching the pre-COVID peak of 7.8% in FY December 2017, or the cyclical recovery print of a margin compounding post-COVID base effect, inbound tourism FX tailwind and partial inflation pass-through that normalises toward 5.0–5.5%. The fair value dispersion is almost entirely a dispersion of this number. The consolidated forward P/E at 32.6x reads on the recovery print extrapolated linearly ; the mid-cycle reconstruction reads on the structural floor.
The consensus reading takes the recovery as the new mid-cycle. Forward earnings extrapolate the 6.5% margin and the +14.1% revenue growth into 7.0–8.0% structural margin on 3–5% organic growth, justifying continued premium to mid-tier comparables.
The variant reading decomposes the FY December 2025 margin into three layers. A structural floor of approximately 5.0–5.5% rests on the suburban family-dining footprint absorbing structural cost inflation. A semi-structural component of approximately 50–100 bps rests on automation rollout and Syabu-Yo mix shift, observable in the labor/revenue ratio compressing 100–200 bps cumulated since FY December 2022. A cyclical component of approximately 50–150 bps rests on the post-COVID base effect, inbound tourism FX tailwind on Tokyo urban tickets, and partial inflation pass-through. Mid-cycle reconstructs to 5.7–6.2%.
Four quarterly EBIT margin prints between February 2027 and August 2027 — Q4 FY December 2026, then Q1, Q2, Q3 FY December 2027 — close the debate empirically. Two consecutive prints below 5.5% compress fair value toward ¥650–900. Two consecutive prints sustained above 7.0% unlock the bull case sequence.
Position framing is no allocation at current levels. Conviction is moderate on the directional thesis ; the absence of a near-term bearish catalyst contains short conviction. Watchlist status with quarterly monitoring of the four prints.
The eleven-year window from FY December 2015 to FY December 2025 reads as three sequential regimes. Mature optimisation through FY December 2019, with the EBIT margin compressing from 7.9% to 5.5% under accumulated wage-pressure absorption pre-automation, DPS rising from ¥12.7 to ¥38, and net debt low at ¥132bn. COVID and partial recovery FY December 2020 through FY December 2022, with an operating loss of ¥23bn in FY December 2020, a ¥42.8bn capital-stock raise in FY December 2021 that diluted share count from 197.5m to 227.5m, dividend cut to zero across FY December 2021–2022, a second EBIT loss of ¥5.6bn in FY December 2022 under input inflation. Recovery and re-pricing FY December 2023 through FY December 2025, with revenue scaling from ¥355bn to ¥458bn, EBIT margin recovering from 3.3% to 6.5%, dividend reinstated at ¥22 in FY December 2025, and treasury-stock balance still at zero throughout.
| Inflection | FY Dec 2015Pre-pressure | FY Dec 2017Margin peak | FY Dec 2020COVID trough | FY Dec 2022Inflation hit | FY Dec 2025Recovery print |
|---|---|---|---|---|---|
| Revenue (¥bn) | 351.1 | 359.4 | 288.4 | 303.7 | 457.8 |
| EBIT (¥bn) | 27.8 | 28.1 | −23.0 | −5.6 | 30.0 |
| EBIT margin | 7.9% | 7.8% | −8.0% | −1.8% | 6.5% |
| EBITDA margin | 20.4% | 18.2% | 9.8% | 13.8% | 17.9% |
| FCF (¥bn) | 15.7 | 14.8 | 22.5 | 32.4 | 51.9 |
| Capex (¥bn) | −17.2 | −16.7 | −14.2 | −13.3 | −22.6 |
| Net debt (¥bn) | 132.1 | 116.7 | 240.8 | 192.8 | 213.3 |
| Net Income (¥bn) | 15.1 | 15.5 | −17.2 | −6.4 | 16.7 |
| Diluted EPS (¥) | 76.98 | 78.95 | −87.16 | −28.00 | 73.62 |
| DPS (¥) | 12.7 | 38.0 | 10.0 | 0.0 | 22.0 |
Source: Data pack 19 May 2026. EBITDA margins are reported series ; pre-IFRS 16 prints (FY December 2015 and FY December 2017) include rental-expense add-back, post-IFRS 16 prints (FY December 2020, FY December 2022, FY December 2025) read EBIT plus D&A directly with lease costs capitalised. The mechanical reset on IFRS 16 adoption from FY December 2019 raises net debt from ~¥118bn to ~¥235bn on lease capitalisation (data point between FY December 2017 and FY December 2020 not shown). Diluted EPS reflects 197.5m shares pre-FY December 2021 capital raise and 227.5m post.
The discipline since FY December 2023 — Net Debt/EBITDA stable at 2.60x, dividend reinstated at ¥22 for a 0.78% yield, capex stepping up to ¥22.6bn in FY December 2025 — is corrective on the balance sheet and absent on shareholder return. The Management pillar at 2.5/5 captures this directly.
The engine runs on a saturated suburban footprint. Approximately 3,000 stores in Japan generate ¥150m of revenue per store on average. Gusto, the dominant family-dining banner at an estimated 50–55% of consolidated revenue, operates at 4–6% segment margin in mature suburban locations and 6–8% in Tokyo urban locations exposed to inbound traffic. Syabu-Yo, the only banner in organic expansion at an estimated 8–12% of consolidated revenue and net unit growth of +10–15% per year, operates at 8–10% segment margin and 10–13% unit ROIC. The dispersion between the two ends of the portfolio sits at approximately 400 bps — below the 500 bps threshold that would justify cellular SOTP. The consolidated multiple is the appropriate read.
Pricing power is structurally weaker than specialist comparables in the sub-industry. The 2022–2024 input inflation cycle of +18–25% on food costs was absorbed at an estimated 60–75% pass-through to the consumer, against Sukiya's documented 100% pass-through on beef-bowl pricing and Marugame's seasonal-fairs differentiation. The FY December 2025 EBIT margin at 6.5% remains 130 bps below the FY December 2017 pre-COVID peak of 7.8% despite three years of favorable cycle conditions. Gross margin compressed from 69.6% in FY December 2019 to 66.7% in FY December 2025. The format is value-positioned at Gusto, which limits the ticket leverage available to the operator.
The EBITDA/EBIT ratio at 2.75x in FY December 2025 reflects the IFRS 16 capitalisation step-up. D&A at ¥52.2bn or 11.4% of revenue sits structurally above what an asset-light comparable would carry — operating-lease commitments capitalised since FY December 2019. The 17.9% EBITDA margin reads optically attractive ; it does not measure the cash-generating economics of the model. EV/EBIT at 24.8x is the relevant multiple for cross-sectional comparison, against the EV/EBITDA at 9.2x that the consensus uses for headline screens.
Labor cost has accelerated through Shunto wage resets. Automation rollout — BellaBot service robots, ordering kiosks, IT modernisation — started post-COVID, three to five years behind Sushiro's Auto Waiter deployed from 2018. The cumulative compression of the labor/revenue ratio is estimated at 100–200 bps across FY December 2022–2025 and approaches the structural floor of what automation can deliver in the family-dining suburban format. The wage hurdle continues to lift on the cost side without compensating differentiation on the pricing side.
FCF/EBIT ratio at FY December 2025 of 1.7x reflects favorable working capital and a depreciation/capex spread that does not normalise mid-cycle. The cumulative eleven-year FCF of ~¥372bn against cumulative EBIT of ~¥186bn produces a 2.0x cycle ratio that masks the COVID years of negative operating profit. At normalisation, the FCF/EBIT ratio compresses toward 0.8–1.0x in line with mature mid-tier comparables. Mid-cycle FCF reconstructs to ¥25–28bn against the FY December 2025 print of ¥51.9bn. The FCF yield at spot is 8.1% on the reported print and 4.0% on the mid-cycle reconstruction. The mid-cycle FCF yield does not anchor the floor of the valuation at current price. At a Japan cost of equity reconstruction band of 6.5–7.5%, mid-cycle FCF yield sits below cost of capital. Cost of equity per WACC build for FY December 2025 is 6.89%.
Eleven years of cumulated free cash flow at approximately ¥372bn against treasury-stock balance of zero throughout. The capital went to dividends at ~¥46bn cumulated, to capex carrying the IFRS 16 lease build-out, and to debt service of the long-term stock that net-increased by ¥81bn over the cycle (largely the FY December 2019 IFRS 16 capitalisation step-up). No buyback program, including across FY December 2023–2025 with the share price drawing down −21% on three months and −13% YTD 2026 from a level that reconstructs to ¥1,000–1,350. Net Debt/EBITDA stable at 2.60x captures genuine balance-sheet discipline. Capital allocation alignment with the equity holder is the documented frailty. The FY December 2021 equity raise of ¥42.8bn priced near the COVID trough diluted share count by 15% from 197.5m to 227.5m — the dilution remains unreversed five years later.
Operational scale at approximately 3,000 stores supported by a mutualised central kitchen and central purchasing platform that serves all banners. Replication is costly for a new entrant ; replicated economics already exist at scale at Zensho via MMD vertical integration. The scale advantage does not translate into margin superiority — Skylark FY December 2025 EBIT margin at 6.5% prints below Food & Life consolidated at 8.4%, below Toridoll Marugame Domestic segment at 17.8%, and at parity with Zensho consolidated at 6.4%. Pricing power is value-positioned at Gusto, limiting ticket leverage. No digital moat — no proprietary app with paid retention, no IC-chip-equivalent loyalty captive, no algorithm-driven yield management. The 60–75% inflation pass-through across 2022–2024 versus Sukiya's 100% measures the gap.
Suburban-led family-dining demand exposed to declining demographics at ~−0.5 to −1.0% per year. Inbound urban Tokyo tailwind on Gusto, exposed to JPY mean-reversion. No contractual recurrence.
Mid-cycle EBIT margin reconstructs to 5.7–6.2%. Return on Capital reported 4.6% in FY December 2025 ; lease-adjusted reconstructed to 3–5% with negative spread to cost of equity 6.89%.
Dividend reinstated at ¥22 for 0.78% yield. Payout 30–40% Net Income. Zero treasury stock against ¥372bn cumulated FCF and a share price 60% above reconstructed fair value.
Below Toridoll (16.5/25, SOTP optionality on Marugame Domestic), below Food & Life (19–20/25, organic compounder with Overseas leg proven), at parity with Saizeriya (14–15/25). The grade does not justify the consolidated forward P/E at 32.6x. Archetype-B mid-tier international comparables — Darden at 17–19x, Cracker Barrel at 12–14x — anchor the appropriate multiple at 15–18x mid-cycle. The compression has not yet completed.
Is the 6.5% FY December 2025 EBIT margin a structural mid-cycle floor or a cyclical recovery peak ?
Does Management announce a material buyback at current prices ?
Eleven years of cumulated FCF at approximately ¥372bn and zero treasury stock. The dividend at ¥22 returns ¥5bn per year against current FCF of ¥52bn. The share price drew down −21% on three months and −13% YTD 2026 from a level the variant reconstruction prices 60% above fair value. A buyback announcement of ¥50bn per year over FY December 2026–2027 would compress share count by ~5% annually, close approximately 5–10% of the discount on its own, and signal management conviction that the share is undervalued. The base case does not assign it.
Does the market complete the multiple compression toward 15–18x ?
Forward P/E at 32.6x against the 5Y average of 82.5x marks a −60% compression already realised since the BoJ NIRP peak. The compression toward archetype-B mid-tier international comparables — Darden at 17–19x, Cracker Barrel at 12–14x — has not completed. The market continues to price mature defensiveness as a premium even where the absence of an Overseas leg, the absence of a buyback program, and the absence of a moat translating into margin superiority document the discount that comparables apply.
At ¥2,830 spot and 32.6x forward P/E, the market is pricing Skylark as a mature defensive name re-rated post-COVID with FY December 2025 earnings extrapolating into structural mid-cycle. Two implicit anchoring choices do the work. The diluted EPS forward consensus implied at ~¥87 reads off the LTM print of ¥73.62 extended by margin expansion toward 7.0–8.0% mid-cycle. The 5Y P/E average of 82.5x serves as the residual mean-reversion target rather than mid-tier archetype comparables at 15–18x. Neither anchor survives the mid-cycle reconstruction. The compression toward 15–18x prescribed by the comparable set has not completed ; the forward P/E sits 75–115% above where the variant reading positions it.
EBIT margin compresses toward 5.0–5.5% mid-cycle over two consecutive prints in FY December 2027 under demographic-driven SSS at −1.0 to −1.5% and accelerating wage inflation absorbing the automation gain. JPY appreciates toward ¥125–130/USD, compressing inbound tourism contribution at Tokyo urban Gusto. Forward P/E compresses to 13–15x in line with Cracker Barrel comparable. EPS mid-cycle at ¥50–60 produces fair value of ¥650–900. The downside combines timing compression and partial permanent loss — Skylark will not become an organic compounder, and three structural ceilings are confirmed.
EBIT margin sustains 5.7–6.2% mid-cycle across the four prints with SSS Japan stable at 0% to +1%. Automation rollout continues to compress labor ratio at −50 to −100 bps per year. Syabu-Yo expands at +10–15% net openings per year without transforming consolidated mix before FY December 2028. JPY stabilises around 145–150/USD without material mean-reversion. Forward P/E compresses toward 15–18x archetype-B mid-tier comparable. EPS mid-cycle at ¥65–75 produces fair value of ¥1,000–1,350.
EBIT margin sustained above 7.0% across four consecutive prints with SSS Japan at +3% on durable pricing power. Management announces a buyback program of ¥50bn per year over three years, compressing share count by approximately 15% by FY December 2028. Syabu-Yo accelerates to +15–18% net openings per year with confirmed segment margin above 9%. Forward P/E re-rates toward 18–22x. EPS at ¥80–90 produces fair value of ¥1,440–1,980. The bull case still sits −40% below spot — the dislocation is too large for any single-scenario reversal.
| KPI | Latest value | Status | What it tells us |
|---|---|---|---|
| Consolidated EBIT margin | 6.5% (FY25) | Cardinal | The number governing the dossier. Four prints between February 2027 and August 2027 close Debate 1. Sustained ≥7.0% validates consensus ; below 5.5% on two consecutive prints triggers bear case. |
| SSS Japan (4 quarters consecutive) | not disclosed | Trigger | Sustained ≥+3% across four quarters is one of three signals invalidating the variant thesis. Below 0% on two prints confirms bear demographic erosion. |
| Buyback announcement ≥¥50bn/year | none | Trigger | Bull-confirmation signal. Closes approximately 5–10% of the discount on its own, confirms management alignment, requalifies the dossier. |
| Syabu-Yo net unit growth | ~+10–15% (est.) | Watch | Acceleration above +15% per year with segment margin above 9% confirmed across four prints is the third bull-confirmation signal. |
| Diluted EPS (FY December 2025) | ¥73.62 | Reference | Sits 21% below the FY December 2016 peak of ¥92.8 split-unchanged. Anchors the gap between the recovery print and the pre-COVID benchmark. |
| Treasury stock balance | ¥0 | Reference | Eleven years of approximately ¥372bn cumulated FCF, zero buyback. Captures the Management pillar at 2.5/5 in a single number. |
| FCF Yield (spot LTM / mid-cycle) | 8.1% / 4.0% | Asymmetric | Mid-cycle reconstruction at 4.0% sits below Japan cost of equity at 6.89% per WACC build. No floor support at current price. |
| Net debt / EBITDA | 2.60x | Holding | IFRS 16 inflated. Stable post-COVID. Capacity for a buyback exists if the alignment shifts. |
| Forward P/E vs archetype-B mid-tier | 32.6x vs 15–18x | Reference | Premium of 75–115% over Darden (17–19x) and Cracker Barrel (12–14x). The compression target. |
| JPY/USD spot | ~155 | Watch | Mean-reversion toward ¥125–130 compresses inbound tourism EBIT contribution by approximately ¥1–2bn per year — one of three bear-case triggers. |
Two consecutive EBIT margin prints sustained above 7.0% across FY December 2026–2027 with SSS Japan at +3% confirm the consensus reading and reframe the dossier toward 18–22x forward P/E. Mid-cycle EPS reconstructs higher toward ¥80–90 and fair value lifts toward ¥1,440–1,980. The downside compression no longer carries.
A buyback announcement above ¥50bn per year over three years would compress share count by approximately 15% by FY December 2028, close 5–10% of the discount on its own, and signal that management considers the share undervalued. The Management pillar lifts from 2.5/5 toward 3.5/5 and triggers re-underwriting.
Syabu-Yo net unit growth sustained at +15–18% per year with confirmed segment margin above 9% across four consecutive prints documents the only organic compounder leg available to the portfolio. Combined with the EBIT margin and buyback signals, the variant thesis is invalidated.
The bear confirmation is two consecutive EBIT margin prints below 5.5% with SSS Japan negative and JPY appreciation toward ¥125–130/USD. Fair value compresses toward ¥650–900 and the dislocation versus spot widens.
The information provided on this website is for informational and educational purposes only and should not be construed as financial, investment, legal, or tax advice. All content reflects the personal opinions, interpretations, and analyses of the author at the time of writing and is subject to change without notice. Nothing contained herein constitutes, or should be interpreted as, a recommendation, solicitation, or offer to buy or sell any securities, financial instruments, or other investment products. The author is not a licensed financial advisor, broker, or investment professional. Any references to specific assets, markets, or strategies are illustrative in nature and do not constitute personalized investment advice. Investing in financial markets involves risk, including the potential loss of capital. Past performance is not indicative of future results. Readers are solely responsible for their own investment decisions and should conduct their own independent research and due diligence before making any financial commitments. You are strongly encouraged to consult with a qualified financial advisor, legal professional, or other relevant specialist before making any investment or financial decisions. By accessing and using this blog, you agree that the author shall not be held liable for any direct or indirect losses, damages, or consequences arising from the use of, or reliance on, the information presented herein. All content is provided "as is" without any warranties of completeness, accuracy, or reliability.